Subtopic Deep Dive
Aortic Atherosclerosis and Stroke Risk
Research Guide
What is Aortic Atherosclerosis and Stroke Risk?
Aortic atherosclerosis and stroke risk examines the association between aortic arch atheroma thickness, plaque complexity, and recurrent ischemic cerebrovascular events.
Studies identify aortic arch plaques ≥4 mm thick as predictors of recurrent brain infarction (Amarenco et al., 1996, 568 citations). Aortic atherosclerotic disease serves as an embolic source for stroke, confirmed via transesophageal echocardiography (Kronzon and Tunick, 2006, 293 citations). Research spans plaque morphology and antithrombotic trials, with over 2,500 citations across key papers.
Why It Matters
Aortic arch plaques ≥4 mm increase recurrent stroke risk fourfold, guiding secondary prevention in cryptogenic stroke patients (Amarenco et al., 1996). Antithrombotic strategies like clopidogrel plus aspirin reduce vascular events compared to warfarin in patients with severe arch atheroma (Amarenco et al., 2014). These findings refine stroke etiology classification, influence anticoagulation protocols, and inform surgical cannulation site selection in aortic disease (Sabik et al., 1995; Dávila-Román et al., 1994).
Key Research Challenges
Heterogeneity in Plaque Assessment
Transesophageal echocardiography varies in detecting plaque thickness and ulceration across studies, complicating risk stratification (Amarenco et al., 1996). Meta-analyses highlight interstudy heterogeneity in vascular calcification risk estimates (Rennenberg et al., 2009). Standardization of imaging protocols remains unresolved.
Optimal Antithrombotic Therapy
Trials show clopidogrel plus aspirin superiority over warfarin for arch plaques, but long-term outcomes need validation (Amarenco et al., 2014). Homocysteine-lowering vitamins failed to reduce events post-angiography (Ebbing et al., 2008). Balancing bleeding and ischemic risks persists as a dilemma.
Embolism Source Attribution
Distinguishing aortic atheroma from cardiac sources in cryptogenic stroke requires advanced imaging (Kronzon and Tunick, 2006). Ascending aorta atherosclerosis predicts cerebrovascular events independently in cardiac patients (Dávila-Román et al., 1994). Plaque rupture mechanisms demand better pathologic correlation (van der Wal, 1999).
Essential Papers
Atherosclerotic Disease of the Aortic Arch as a Risk Factor for Recurrent Ischemic Stroke
The French Study of Aortic Plaques in Stroke Group, Pierre Amarenco, A Cohen et al. · 1996 · New England Journal of Medicine · 568 citations
Atherosclerotic plaques > or = 4 mm thick in the aortic arch are significant predictors of recurrent brain infarction and other vascular events.
Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis
Roger Rennenberg, Kessels, Leon J. Schurgers et al. · 2009 · Vascular Health and Risk Management · 455 citations
The presence of calcification in any arterial wall is associated with a 3-4-fold higher risk for mortality and cardiovascular events. Interpretation of the pooled estimates has to be done with caut...
Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography
Marta Ebbing, Øyvind Bleie, Per Magne Ueland et al. · 2008 · JAMA · 412 citations
clinicaltrials.gov Identifier: NCT00354081.
Axillary artery: An alternative site of arterial cannulation for patients with extensive aortic and peripheral vascular disease
Joseph F. Sabik, Bruce W. Lytle, Patrick M. McCarthy et al. · 1995 · Journal of Thoracic and Cardiovascular Surgery · 380 citations
Atherosclerotic plaque rupture – pathologic basis of plaque stability and instability
Allard C. van der Wal · 1999 · Cardiovascular Research · 317 citations
Time for primary reveiw 27 days Atherosclerosis continues to be one of the main subjects in pathology research. The intriguing complexity of its pathogenesis as well as the importance of its clin...
Aortic Atherosclerotic Disease and Stroke
Itzhak Kronzon, Paul A. Tunick · 2006 · Circulation · 293 citations
Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
Christodoulos Stefanadis, C. Antoniou, Dimitris Tsiachris et al. · 2017 · Journal of the American Heart Association · 269 citations
Reading Guide
Foundational Papers
Start with Amarenco et al. (1996, 568 citations) for core risk evidence of ≥4 mm plaques; follow with Kronzon and Tunick (2006, 293 citations) for aortic disease-stroke mechanisms; Dávila-Román et al. (1994, 236 citations) for ascending aorta predictions.
Recent Advances
Amarenco et al. (2014, 195 citations) details antithrombotic trial outcomes; Stefanadis et al. (2017, 269 citations) covers vulnerable plaque perspectives applicable to aorta.
Core Methods
Transesophageal echocardiography measures plaque thickness and ulceration (Amarenco et al., 1996; Kronzon and Tunick, 2006); meta-analysis pools calcification risks (Rennenberg et al., 2009); randomized trials test antiplatelets vs. anticoagulants (Amarenco et al., 2014).
How PapersFlow Helps You Research Aortic Atherosclerosis and Stroke Risk
Discover & Search
Research Agent uses searchPapers and citationGraph to map 568-citation foundational work by Amarenco et al. (1996) to therapy trials like Amarenco et al. (2014), revealing antithrombotic gaps. exaSearch uncovers heterogeneous calcification studies (Rennenberg et al., 2009), while findSimilarPapers links plaque rupture pathology (van der Wal, 1999) to stroke risk.
Analyze & Verify
Analysis Agent employs readPaperContent on Amarenco et al. (1996) abstracts to extract ≥4 mm plaque risk ratios, then verifyResponse with CoVe checks claims against Kronzon and Tunick (2006). runPythonAnalysis performs meta-analysis on event rates from Ebbing et al. (2008) and Rennenberg et al. (2009) using pandas for pooled hazard ratios; GRADE grading scores evidence quality for anticoagulation recommendations.
Synthesize & Write
Synthesis Agent detects gaps in long-term outcomes post-Amarenco et al. (2014) trial and flags contradictions between vitamin therapy failures (Ebbing et al., 2008) and plaque stability models (van der Wal, 1999). Writing Agent uses latexEditText for risk stratification tables, latexSyncCitations for 10-paper bibliographies, and latexCompile for review manuscripts; exportMermaid visualizes embolism pathways from aortic arch to brain.
Use Cases
"Run meta-analysis on aortic plaque thickness and recurrent stroke hazard ratios from top papers."
Research Agent → searchPapers('aortic arch atheroma stroke') → Analysis Agent → runPythonAnalysis(pandas meta-analysis on Amarenco 1996 + Rennenberg 2009 event data) → pooled HR output with GRADE scores and matplotlib forest plot.
"Draft LaTeX review section on antithrombotic trials for aortic atherosclerosis stroke prevention."
Synthesis Agent → gap detection (Amarenco 2014 vs Ebbing 2008) → Writing Agent → latexEditText(structured paragraph) → latexSyncCitations(9 papers) → latexCompile(PDF section with figure captions on plaque imaging).
"Find GitHub repos analyzing TEE images for aortic plaque detection linked to these papers."
Research Agent → paperExtractUrls(Kronzon 2006) → paperFindGithubRepo(TEE segmentation models) → githubRepoInspect(code for plaque volume quantification) → exportCsv of repo metrics and stroke risk correlations.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ aortic atheroma papers, chaining searchPapers → citationGraph → DeepScan for 7-step verification of plaque ≥4 mm risks (Amarenco et al., 1996). DeepScan analyzes imaging heterogeneity across Rennenberg et al. (2009) meta-data with runPythonAnalysis checkpoints. Theorizer generates hypotheses on plaque ulceration embolization from van der Wal (1999) pathology integrated with Kronzon (2006).
Frequently Asked Questions
What defines high-risk aortic atherosclerosis for stroke?
Plaques ≥4 mm thick in the aortic arch predict recurrent ischemic stroke (Amarenco et al., 1996).
What are key imaging methods for aortic plaques?
Transesophageal echocardiography detects arch atheroma complexity and thickness as embolic sources (Kronzon and Tunick, 2006; Dávila-Román et al., 1994).
What are pivotal papers?
Amarenco et al. (1996, 568 citations) established arch plaques as recurrent stroke risk; Amarenco et al. (2014, 195 citations) compared clopidogrel-aspirin to warfarin.
What open problems exist?
Heterogeneity in calcification risk estimates (Rennenberg et al., 2009) and optimal therapy beyond dual antiplatelets (Amarenco et al., 2014) remain unresolved.
Research Aortic Thrombus and Embolism with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Aortic Atherosclerosis and Stroke Risk with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Aortic Thrombus and Embolism Research Guide